Morgan Stanley upgraded Charles River Laboratories stock to Overweight on June 22, 2026.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Charles River Laboratories →

  major US biomedical company

  • Agilent Technologies and Charles River Laboratories are both companies operating in the life sciences sector.Sat 11:57
  • Apollo is the digital client engagement platform for Charles River Laboratories, and Mark Mintz serves as CIO and head of global shared services.Sat 11:57

Related events

• Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.Sep 3
• Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.Sep 10
• Morgan Stanley provided research notes and an Overweight rating on Gilead Sciences stock on September 20, 2026.Sep 22
• Morgan Stanley reaffirmed an overweight rating and raised the price target on Flywire stock.Sep 2
• Morgan Stanley analyst provides Overweight rating for SpaceX.Sep 5